Dr. Reddy's Laboratories has expected Russia's COVID-19 vaccine Sputnik V, under phase 3 trials being conducted by the city-based drug maker, to be launched in India through Emergency Use Authorisation (EUA) by March this year.
The ongoing trial was expected to be completed by February after which it would approach the Drug Controller General of India (DCGI) for EUA and based on its approval the vaccine could be launched in March. The company partnered with Russian Direct Investment Fund (RDIF) in September to conduct the clinical trials of the Sputnik V vaccine and for its distribution rights in India.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1674.00 |
| Dr. Reddys Lab | 1221.00 |
| Cipla | 1230.55 |
| Zydus Lifesciences | 930.45 |
| Lupin | 2323.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: